(19)
(11) EP 2 699 262 A2

(12)

(88) Date of publication A3:
03.01.2013

(43) Date of publication:
26.02.2014 Bulletin 2014/09

(21) Application number: 12718626.0

(22) Date of filing: 20.04.2012
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
C07K 16/32(2006.01)
C07K 16/28(2006.01)
A61K 47/48(2006.01)
A61P 35/00(2006.01)
C07K 16/10(2006.01)
C07K 16/46(2006.01)
(86) International application number:
PCT/EP2012/057307
(87) International publication number:
WO 2012/143524 (26.10.2012 Gazette 2012/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 20.04.2011 WO PCT/EP2011/056388
20.04.2011 DK 201100312
27.05.2011 WO PCT/EP2011/058772
27.05.2011 WO PCT/EP2011/058779
27.10.2011 DK 201100824
27.10.2011 US 201161552286 P

(71) Applicant: Genmab A/S
1260 Copenhagen K (DK)

(72) Inventors:
  • NEIJSEEN, Joost, J.
    NL-3584 CM Utrecht (NL)
  • MEESTERS, Joyce, I.
    NL-3584 Utrecht (NL)
  • DE GOEIJ, Bart
    NL-3584 CM Utrecht (NL)
  • LABRIJN, Aran, Frank
    NL-3584 CM Utrecht (NL)
  • PARREN, Paul
    NL-3584 CM Utrecht (NL)
  • SCHUURMAN, Janine
    NL-3584 CM Utrecht (NL)

(74) Representative: Genmab A/S 
Bredgade 34 E
1260 Copenhagen K
1260 Copenhagen K (DK)

   


(54) BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3